Azitra (AZTR) Shares Outstanding (2022 - 2026)
Azitra (AZTR) reported Shares Outstanding of $16.2 million for Q1 2026, up 619.95% on a YoY basis from $2.2 million in Q1 2025, and up 50.76% quarter-over-quarter from $10.7 million in Q4 2025.
Azitra (AZTR) Shares Outstanding (2022 - 2026) Analysis & Trends
Azitra has reported Shares Outstanding for 5 years, with the latest figure at $16.2 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding rose 619.95% year-over-year to $16.2 million; the trailing twelve-month figure through Mar 2026 stood at $16.2 million (up 619.95% YoY), and the FY2025 full-year result was $10.7 million, up 838.02% from the prior year.
- Shares Outstanding for Q1 2026 stood at $16.2 million, up from $10.7 million in the prior quarter.
- The five-year high for Shares Outstanding was $16.2 million in Q1 2026, with the low at $34791.0 in Q4 2022.
- Historically, Shares Outstanding has averaged $2.8 million across 5 years, with a median of $1.0 million in 2023.
- The largest YoY upside for Shares Outstanding was 1791.53% in 2024 against a maximum downside of 86.19% in 2024.
- Azitra's Shares Outstanding stood at $34791.0 in 2022, then jumped by 74.0% to $60535.0 in 2023, then surged by 1791.53% to $1.1 million in 2024, then surged by 838.02% to $10.7 million in 2025, then soared by 50.76% to $16.2 million in 2026.
- The last three Shares Outstanding figures came in at $16.2 million (Q1 2026), $10.7 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 40.14 Bn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 91.57 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | 16.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.19 Mn |
| Mar 31, 2026 | 16.19 Mn |
| Mar 31, 2026 | 16.19 Mn |
| Mar 31, 2026 | 16.19 Mn |
| Mar 31, 2026 | 16.19 Mn |
| Mar 31, 2026 | 16.19 Mn |
| Mar 31, 2026 | 16.19 Mn |
| Mar 31, 2026 | 16.19 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Sep 30, 2025 | 5.60 Mn |
| Sep 30, 2025 | 5.60 Mn |
| Sep 30, 2025 | 5.60 Mn |
| Sep 30, 2025 | 5.60 Mn |